Login / Signup
Bomiao Hu
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 7
Top Topics
Emergency Department
Adverse Drug
Advanced Non Small Cell Lung Cancer
Rna Seq
Top Venues
Cancer research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Bomiao Hu
,
Marc Wiesehöfer
,
Fernando J de Miguel
,
Zongzhi Z Liu
,
Lok Hei Chan
,
Jungmin Choi
,
Mary Ann Melnick
,
Anna Arnal-Estape
,
Zenta Walther
,
Dejian Zhao
,
Francesc Lopez
,
Anna Wurtz
,
Guoping Cai
,
Rong Fan
,
Scott N Gettinger
,
Andrew Z Xiao
,
Qin Yan
,
Robert J Homer
,
Don X Nguyen
,
Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.
Cancer research
(2024)
Bomiao Hu
,
Marc Wiesehöfer
,
Fernando J de Miguel
,
Zongzhi Z Liu
,
Lok Hei Chan
,
Jungmin Choi
,
Mary Ann Melnick
,
Anna Arnal-Estape
,
Zenta Walther
,
Dejian Zhao
,
Francesc Lopez
,
Anna Wurtz
,
Guoping Cai
,
Rong Fan
,
Scott N Gettinger
,
Andrew Z Xiao
,
Qin Yan
,
Robert J Homer
,
Don X Nguyen
,
Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.
Cancer research
84 (8) (2024)
Bomiao Hu
,
Marc Wiesehöfer
,
Fernando J de Miguel
,
Zongzhi Z Liu
,
Lok Hei Chan
,
Jungmin Choi
,
Mary Ann Melnick
,
Anna Arnal-Estape
,
Zenta Walther
,
Dejian Zhao
,
Francesc Lopez
,
Anna Wurtz
,
Guoping Cai
,
Rong Fan
,
Scott N Gettinger
,
Andrew Z Xiao
,
Qin Yan
,
Robert J Homer
,
Don X Nguyen
,
Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.
Cancer research
84 (8) (2024)
Bomiao Hu
,
Marc Wiesehöfer
,
Fernando J de Miguel
,
Zongzhi Z Liu
,
Lok Hei Chan
,
Jungmin Choi
,
Mary Ann Melnick
,
Anna Arnal-Estape
,
Zenta Walther
,
Dejian Zhao
,
Francesc Lopez
,
Anna Wurtz
,
Guoping Cai
,
Rong Fan
,
Scott N Gettinger
,
Andrew Z Xiao
,
Qin Yan
,
Robert J Homer
,
Don X Nguyen
,
Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.
Cancer research
84 (8) (2024)
Bomiao Hu
,
Marc Wiesehöfer
,
Fernando J de Miguel
,
Zongzhi Z Liu
,
Lok Hei Chan
,
Jungmin Choi
,
Mary Ann Melnick
,
Anna Arnal-Estape
,
Zenta Walther
,
Dejian Zhao
,
Francesc Lopez
,
Anna Wurtz
,
Guoping Cai
,
Rong Fan
,
Scott N Gettinger
,
Andrew Z Xiao
,
Qin Yan
,
Robert J Homer
,
Don X Nguyen
,
Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.
Cancer research
84 (8) (2024)
Bomiao Hu
,
Marc Wiesehöfer
,
Fernando J de Miguel
,
Zongzhi Z Liu
,
Lok Hei Chan
,
Jungmin Choi
,
Mary Ann Melnick
,
Anna Arnal-Estape
,
Zenta Walther
,
Dejian Zhao
,
Francesc Lopez
,
Anna Wurtz
,
Guoping Cai
,
Rong Fan
,
Scott N Gettinger
,
Andrew Z Xiao
,
Qin Yan
,
Robert J Homer
,
Don X Nguyen
,
Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.
Cancer research
84 (8) (2024)
Bomiao Hu
,
Marc Wiesehöfer
,
Fernando J de Miguel
,
Zongzhi Z Liu
,
Lok Hei Chan
,
Jungmin Choi
,
Mary Ann Melnick
,
Anna Arnal-Estape
,
Zenta Walther
,
Dejian Zhao
,
Francesc Lopez
,
Anna Wurtz
,
Guoping Cai
,
Rong Fan
,
Scott N Gettinger
,
Andrew Z Xiao
,
Qin Yan
,
Robert J Homer
,
Don X Nguyen
,
Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.
Cancer research
84 (8) (2024)